Abstract
Purpose
To evaluate the dynamics of the determinants of returning to work (RTW) in a population of patients treated for breast cancer (BC) in a real-world setting.
Method
We conducted a retrospective study including 1278 BC patients working or looking for work at the time of diagnosis. We performed a focused principal component analysis to highlight the dimensions of a persistent decline in work capacity. Logistic regression analyses were performed to identify correlates of non-RTW 1 and 2 years after treatment.
Results
One-third (31%, n = 389) of patients continued working during treatment. At study inclusion, 1100 patients had returned to work (89%). Three-quarters (n = 508, 75%) of the women reported a decline in work capacity 1 year after RTW and 22% (n = 148) presented a persistent decline in work capacity 2 years after the diagnosis. The odds ratio for non-RTW at 1 year was significantly higher for patients treated with a combination of chemotherapy and trastuzumab (OR = 1.72, 95% CI [1.07–2.76]), manual workers (OR = 3.99, 95% CI [1.54–10.81]), patients with lower incomes (OR = 2.33, 95% CI [1.29–4.19]), and patients experiencing fatigue (OR = 1.81, 95% CI [1.34–2.48]). The odds ratio for non-RTW at 2 years was higher for various occupational categories (OR = 3.49, 95% CI [1.89–6.74] for clerks, OR = 4.58, 95% CI [1.48–12.82] for self-employed workers, OR = 8.98, 95% CI [2.69–27.89] for manual workers), patients with comorbidities (OR = 2.80, 95% CI [1.61–4.93]), and patients experiencing anxiety symptoms (OR = 2.54, 95% CI [1.18–5.76]), while the impact of the type of treatment was no longer significantly associated with RTW.
Conclusion
The determinants of RTW change over time. Patients should be offered supportive interventions tailored to risk factors and time from diagnosis.
Similar content being viewed by others
Data Availability
The use of data is restricted by the French regulations which gave their consent for this study. Data may be requested on a case-by-case basis by contacting the corresponding author.
Code availability
R software.
References
Arfi A, Baffert S, Soilly AL, Huchon C, Reyal F, Asselain B, Neffati S, Rouzier R, Héquet D (2018) Determinants of return at work of breast cancer patients: results from the OPTISOINS01 French prospective study. BMJ Open. 8(5):e020276
Dumas A, Vaz Luis I, Bovagnet T, El Mouhebb M, Di Meglio A, Pinto S, Charles C, Dauchy S, Delaloge S, Arveux P, Coutant C, Cottu P, Lesur A, Lerebours F, Tredan O, Vanlemmens L, Levy C, Lemonnier J, Mesleard C, Andre F, Menvielle G (2019) Impact of breast cancer treatment on employment: results of a multicenter prospective cohort study (CANTO). J Clin Oncol JCO1901726
Bouhnik AD, Bendiane MK, Cortaredona S, Sagaon Teyssier L, Rey D, Berenger C, Seror V, Peretti-Watel P; members of VICAN Group (2015) The labour market, psychosocial outcomes and health conditions in cancer survivors: protocol for a nationwide longitudinal survey 2 and 5 years after cancer diagnosis (the VICAN survey). BMJ Open 5(3)
Institut National du Cancer. Le cancer du sein en chiffres. https://www.e-cancer.fr/Professionnels-de-sante/Les-chiffres-du-cancer-en-France/Epidemiologie-des-cancers/Les-cancers-les-plus-frequents/Cancer-du-sein. Last visited 23rd November 2020
VICAN 5, La vie cinq ans après un cancer. https://www.e-cancer.fr/Presse/Dossiers-et-communiques-de-presse/Cinq-ans-apres-un-diagnostic-de-cancer-la-qualite-de-vie-et-la-situation-en-emploi-restent-fortement-degrades. Last visited 23rd November 2020
Sevellec M, Belin L, Bourrillon MF, Lhuilier D, Rérolle E, Le Bideau S, Cotasson-Guillet F, Le Peltier N, Asselain B (2015) Work ability in cancer patients: six years assessment after diagnosis in a cohort of 153 workers. Bull Cancer 102(6 Suppl 1):S5-13
Héquet D, Huchon C, Soilly AL, Asselain B, Berseneff H, Trichot C, Combes A, Alves K, Nguyen T, Rouzier R, Baffert S (2019) Direct medical and non-medical costs of a one-year care pathway for early operable breast cancer: results of a French multicenter prospective study. PLoS One 14(7):e0210917
Van Muijen P, Weevers NL, Snels IA, Duijts SF, Bruinvels DJ, Schellart AJ, van der Beek AJ (2013) Predictors of return to work and employment in cancer survivors: a systematic review. Eur J Cancer Care (Engl) 22:114–160
Taskila-Brandt T, Martikainen R, Virtanen SV, Pukkala E, Hietanen P, Lindbohm ML (2009) The impact of education and occupation on the employment status of cancer survivors. Eur J Cancer 40:2488–2493
Ahn E, Cho J, Shin DW, Park BW, Ahn SH, Noh DY, Nam SJ, Lee ES, Yun YH (2009) Impact of breast cancer diagnosis and treatment on work-related life and factors affecting them. Breast Cancer Res Treat 116:609–616
Cooper AF, Hankins M, Rixon L, Eaton E, Grunfeld EA (2012) Distinct work-related, clinical and psychological factors predict return to work following treatment in four different cancer types. Psychooncology 22:659–667
Islam T, Dahlui M, Majid HA, Nahar AM, Mohd Taib NA, Su TT; MyBCC study group (2014) Factors associated with return to work of breast cancer survivors: a systematic review. BMC Public Health 14 (Suppl 3):S8
Bauquier C, Pannard M, Préau M (2017) The Seintinelles: an innovative approach to promoting Community-Based Research and sustaining health democracy in oncology. Sante Publique 29(4):547–550
LeBlanc TW, Abernethy AP. Patient-reported outcomes in cancer care - hearing the patient voice at greater volume [published online October 4, 2017]. Nat Rev Clin Oncol
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr, KATHERINE Investigators (2019) Trastuzumab emtansine for residual invasive HER2-positive breast cancer. N Engl J Med 380(7):617–628
Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park KH, Sasano H, Ohashi Y, Toi M (2017) Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med 376(22):2147–2159
Bellagamba G, Descamps A, Cypowyj C, Eisinger F, Villa A, Lehucher-Michel MP (2021) Cancer survivors’ efforts to facilitate return to work. Psychol Health Med 26(7):845–852
Guo YJ, Tang J, Li JM, Zhu LL, Xu JS (2021) Exploration of interventions to enhance return-to-work for cancer patients: a scoping review. Clin Rehabil 35(12):1674–1693
Hatton R, Wallis A, Chew A, Stanley M, Smith A (2021) Return to work and cancer: perspectives of occupational therapists. Aust Occup Ther J. 68(4):298–307
de Boer AG, Taskila TK, Tamminga SJ, Feuerstein M, Frings-Dresen MH, Verbeek JH (2015) Interventions to enhance return-to-work for cancer patients. Cochrane Database Syst Rev. 2015(9):CD007569
Acknowledgements
The authors acknowledge the Seintinelles cancer network.
Author information
Authors and Affiliations
Contributions
Delphine Hequet: conceptualization, methodology, formal analysis, writing—original draft, writing—review and editing
Anne-Sophie Hamy: conceptualization, validation, writing—review and editing
Noemie Girard: formal analysis
Enora Laas: writing—review and editing
Florence Coussy: writing—review and editing
Roman Rouzier: writing—review and editing
Marie Preau: conceptualization, methodology, funding acquisition
Lidia Delrieu: conceptualization, methodology, funding acquisition
Agnes Dumas: conceptualization, methodology, funding acquisition
Fabien Reyal: conceptualization, methodology, funding acquisition
Corresponding author
Ethics declarations
Ethics approval
This study was approved by our ethics committee.
Consent to participate
All the patients in the study gave their consent to participate by completing the online questionnaire.
Consent for publication
NA
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hequet, D., Hamy, AS., Girard, N. et al. Variation over time of the factors influencing return to work and work capacities after a diagnosis of breast cancer: a study on the behalf of the Seintinelles research network. Support Care Cancer 30, 5991–5999 (2022). https://doi.org/10.1007/s00520-022-07000-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-022-07000-x